Budesonide
Budesonide 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Asthma。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
12 项
已进入 III/IV 期
35 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Novartis Pharmaceuticals
- Instituto Nacional de Cancerologia de Mexico
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- AstraZeneca
- Christian Medical College, Vellore, India
- Guangzhou Institute of Respiratory Disease
- Beijing Tongren Hospital
- Assiut University
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
Mexico、丹麦、荷兰、Argentina、Colombia、Egypt、Indonesia、Jordan、Malaysia、Saudi Arabia、中国台湾、Thailand
正在招募患者的 Budesonide 研究
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
II 期招募中MexicoNCT038037873TR Asthma Biologics Cohort (ABC) Study
不适用招募中丹麦荷兰NCT06126692Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
不适用招募中ArgentinaColombiaEgyptIndonesiaNCT07069829Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
IV 期招募中IndiaNCT06676384To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)
不适用招募中中国NCT06772454Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis
II 期招募中中国NCT07499791Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis
IV 期招募中EgyptNCT06209047The Treatment of Moderate to Severe Allergic Rhinitis With Electroacupuncture Combined With Microneedle Knife
不适用招募中中国NCT06890260Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation
不适用招募中中国NCT07877519Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
III 期招募中美国中国MexicoSouth AfricaNCT06307665Nasal Obstruction With Oxymetazoline and Corticosteroids
II 期招募中美国NCT06830109A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
III 期招募中Argentina奥地利BrazilBulgariaNCT05562466Anti-Inflammatory Reliever South Africa
III 期招募中South AfricaNCT06429475A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission
II 期招募中比利时丹麦法国德国NCT07156175Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
I 期 / II 期招募中法国NCT06110403Nefecon and Ambrisentan in IgA Nephropathy
IV 期招募中中国NCT07030894Posterior Nasal Nerve Combined With Anterior Ethmoid Neurotomy for Idiopathic Rhinitis
不适用招募中中国NCT06870292Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
III 期招募中美国NCT05509933Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
IV 期招募中美国NCT04314375A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
III 期招募中中国中国香港NCT06471257Ventilation and Perfusion in Asthmatics
IV 期招募中美国NCT07426458Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction
不适用招募中EgyptNCT07193485Expertise Asthma COPD Program with Digital Support
III 期招募中荷兰NCT05831566Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
IV 期招募中德国荷兰西班牙英国NCT06334575
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。